Sun-Novo(SH:688621) Xin Lang Cai Jing·2025-10-31 05:43Group 1 - The core point of the article highlights the performance of Yangguang Nuohuo, which saw a stock price increase of 5.04% to 58.72 CNY per share, with a trading volume of 174 million CNY and a turnover rate of 2.70%, resulting in a total market capitalization of 6.577 billion CNY [1] - Yangguang Nuohuo is a comprehensive research and development service company established on March 9, 2009, and listed on June 21, 2021, primarily engaged in the development of generic drugs, consistency evaluation, and innovative drug development, with 99.91% of its revenue coming from CRO services [1] Group 2 - From the perspective of major shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund reduced its holdings by 550,000 shares in the third quarter, now holding 2 million shares, which represents 1.79% of the circulating shares, with an estimated floating profit of approximately 5.64 million CNY [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund, managed by Wan Minyuan, has a total asset size of 5.957 billion CNY, with a best return of 144.04% and a worst return of -20.09% during his tenure [3] Group 3 - The Rongtong Health Industry Flexible Allocation Mixed A/B fund has Yangguang Nuohuo as its sixth-largest holding, accounting for 5.44% of the fund's net value, with a floating profit of approximately 5.64 million CNY [4]